P/B
1,4
Certara
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
$1.4B
Market Cap • 10/9/2026
2017
(9 years)
Founded
2020
(6 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
3,4
P/EBITDA
18,4
P/OCF
16,8
P/FCF
17,3
P/E
—
BVPS
6,3
EPS
—
Market Cap
Market Cap
1,4B
EV
1,5B
EV/Revenue
3,7
EV/EBITDA
19,9
EV/EBIT
-2290,8
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
5,4%
Total Yield
5,4%
Payout
0%
Retained Earnings
-193,9M
Profitability
Gross Margin
61,9%
EBITDA Margin
18,5%
EBIT Margin
—
Net Margin
—
D&A/EBITDA
72,4%
R&D/Revenue
10,7%
Capex/Revenue
0,6%
Capex/D&A
3,2%
Capex/OCF
3%
SBC/OCF
37,6%
% PPE
0,8%
% Goodwill
51,3%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
9,3%
CAGR Op. Income 5Y
-54,9%
CAGR Net Income 5Y
4,4%
CAGR EPS 5Y
2,4%
CAGR OCF 5Y
11,7%
Leverage
N.D./EBITDA
1,5
Debt/Equity
0%
Current Ratio
2,6
Quick Ratio
1,5
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!